A team of researchers from the United Kingdom report that Clostridioides difficile spores can survive on hospital sheets even after being washed with high-temperature water and industrial detergents, and that those spores could be contributing to outbreaks of C difficile infection (CDI) in hospitals.
The new study sheds light on prescribing missed in other studies, including for conditions without an in-patient visit.
The results of a small clinical trial in France show that a topical treatment containing a cocktail of bacteriophages successfully reduced bacterial burden in patients with infected burn wounds, but at a significantly slower rate than standard of care. The findings appeared yesterday in The Lancet Infectious Diseases.
Research on the device indicates it has the potential to provide quick, low-cost diagnostics.
Whole-genome sequencing could lead to faster, more accurate resistance testing.
Using a mathematical model that links seasonal patterns of antibiotic use with resistance, researchers from Harvard and the Centers for Disease Control and Prevention (CDC) have found that seasonal changes in population-wide macrolide use is associated with a small rise in azithromycin non-susceptibility in Neisseria gonorrhoeae isolates.
The Coalition for Epidemic Preparedness Innovations (CEPI) recently announced a collaboration with Germany-based IDT Biologika worth up to $36 million to develop and produce a vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV).
A new study in the Journal of Antimicrobial Chemotherapy shows that Internet-based communication training might be a cost-effective way to limit primary care antibiotic prescriptions when compared with C-reactive protein (CRP) testing.
The US Food and Drug Administration (FDA) reported yesterday that French diagnostics firm bioMerieux has recalled two of its antimicrobial susceptibility testing (AST) cards because of false results for some strains of methicillin-resistant Staphylococcus aureus (MRSA).
Finnish researchers are reporting the first transmission of carbapenemase-producing Escherichia coli between humans and dogs.
